(PharmaNewsWire.Com, November 23, 2020 ) According to the new market research report by MarketsandMarkets, the filter integrity test market is projected to reach USD 79 million by 2024 from USD 59 million in 2018, at a CAGR of 5.0% during the forecast period.
Factors such as increasing R&D spending, growth in the biopharmaceutical industry, and increasing purity requirements in the end-user market are driving the growth of the market.
Merck is another major player in the filter integrity test market. The company has a strong geographic presence across the Americas, Europe, Asia Pacific, and the Middle East and Africa. Merck focuses on inorganic strategies to maintain its leading position in this market. For instance, in 2018, the company signed a MoU with Schneider Electric (France) to automate biopharmaceutical processes for China’s biopharmaceutical industry.
The Geographical Landscape of the Diffusion Test Market Include:
The Diffusion Test market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest share of the market, followed by Europe. The increasing demand for biopharmaceuticals and implementation of drug safety guidelines by the FDA are the major factors driving the growth of the filter integrity test industry in North America.
Based on type, the market is segmented into diffusion test, water flow integrity test, and bubble point test. In 2018, the diffusion test segment accounted for the largest share of the filter integrity test market. This segment is also expected to witness the highest growth during the forecast period. The advantages offered by the diffusion testing method such as high sensitivity, high margin of safety, and testing of the complete filter system (cartridge and housing) are supporting the growth of this segment.
Based on mechanism, the Diffusion Test Market is segmented into automated and manual filter integrity tests. Integrity tests based on the automated mechanism accounted for the larger share of the market in 2018. In automated integrity testing, the data is not manually entered into the integrity test instrument, which reduces the risk of human error.
Based on end user, the filter integrity test market is segmented into pharmaceutical and biopharmaceutical companies, CMOs, and other end users. In 2018, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the market
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
